BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Genetown

  VBI Vaccines Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares and Upsized Registered Direct Offering for Aggregate Proceeds of $71.9M

  The pricing for the underwritten public offering was for a total of 16,100,000 common shares.

  October 30, 2017

   · 

  5 min read
• 

  Job Trends

  This is the Fastest-Growing Private Pharma in the Bay Area

  Want to work for a company having a growth spurt?

  October 30, 2017

   · 

  1 min read
• 

  Policy

  Insys Sales Execs Allegedly Made a Rap Video of Themselves Dancing With Their Deadly Fentanyl Spray

  Insys continues to receive an optics beating in the wake of the charges against company founder John Kapoor and multiple executives surrounding illegal sales practices of its cancer pain drug.

  October 30, 2017

   · 

  3 min read

   · 

  Alex Keown
• Business

  CTI BioPharma to Report Third Quarter 2017 Financial Results on November 6, 2017

  CTI BioPharma today announced that management plans to report its third quarter 2017 financial results on Monday, November 6, 2017, after the close of the U.S. financial markets.

  October 30, 2017

   · 

  1 min read
• Business

  Biohaven Announces First Patient Treated in Clinical Research Collaboration At Rutgers Cancer Institute

  Biohaven announced a clinical collaboration today with Drs. Ann Silk and James Goydos at the Rutgers Cancer Institute of New Jersey.

  October 30, 2017

   · 

  5 min read
• Business

  Hemogenyx Pharma Release: LakePharma Appointed As Service Provider for Lead Drug Development

  The relationship between Hemogenyx Pharmaceuticals and LakePharma is designed to have a seamless product development process, from discovery to biomanufacturing

  October 30, 2017

   · 

  5 min read
• Business

  BioScience Managers Expands Team, Adding Significant New International Expertise

  BioScience Managers announced the expansion of its team with the addition of three new directors with broad sector and geographic experience - Dr Michael Perry as a Director, Dennis Purcell as a Director and Senior Expert Advisor, and Nicole Vitullo as an Independent Director.

  October 30, 2017

   · 

  5 min read
• BioMidwest

  Freudenberg Medical Introduces Family of Hemostasis Valves for Interventional and Diagnostic Catheters

  The new hemostasis valve family adds the innovative HyperSeal and CertuSeal valves to the well-received FlexSeal valve launched last year.

  October 30, 2017

   · 

  2 min read
• Drug Development

  Merrimack Receives Orphan Drug Designation for MM-121 for the Treatment of Heregulin Positive Non-Small Cell Lung Cancer

  Merrimack today announced that the FDA has granted orphan drug designation to MM-121, its investigational drug candidate, a fully human monoclonal antibody.

  October 30, 2017

   · 

  5 min read
• Business

  Aerie Pharmaceuticals Announces Appointment of John Maltman, Ph.D., As Vice President of Medical Affairs

  Dr. Maltman will be responsible for leading the strategic efforts of Aerie’s Medical Affairs Department across a broad spectrum of product-related activities.

  October 30, 2017

   · 

  5 min read